© Reuters. Test tubes are seen in front of a displayed Moderna logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration
(Reuters) – Moderna (NASDAQ:) Inc will join the as of the start of trading on July 21, replacing Alexion Pharmaceuticals (NASDAQ:), S&P Dow Jones Indices said in a statement on Thursday.
Moderna shares rose 6% in extended trade after the announcement. The COVID-19 vaccine maker’s stock has surged over 150% this year, elevating its market capitalization to about $100 billion.
Britain’s AstraZeneca (NASDAQ:) said last December it would acquire U.S. biotech Alexion in a $39 billion deal.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Be the first to comment